Cargando…
Morquio B patient/caregiver survey: First insight into the natural course of a rare GLB1 related condition()
Morquio B disease (MBD) or Mucopolysaccharidosis type IV B (MPS IV B) is caused by particular GLB1 mutations specifically affecting the affinity of beta-galactosidase to keratan sulphate, resulting in dysostosis multiplex resembling Morquio A (MPS IV A) disease (GALNS deficiency). Additional neurono...
Autores principales: | Bleier, Maria, Yuskiv, Nataliya, Priest, Tina, Moisa Popurs, Marioara Angela, Stockler-Ipsiroglu, Sylvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072644/ https://www.ncbi.nlm.nih.gov/pubmed/30094186 http://dx.doi.org/10.1016/j.ymgmr.2018.06.006 |
Ejemplares similares
-
Morquio B Disease. Disease Characteristics and Treatment Options of a Distinct GLB1-Related Dysostosis Multiplex
por: Yuskiv, Nataliya, et al.
Publicado: (2020) -
Morquio‐B disease: Clinical and genetic characteristics of a distinct GLB1‐related dysostosis multiplex
por: Abumansour, Iman S., et al.
Publicado: (2019) -
Morquio‐like dysostosis multiplex presenting with neuronopathic features is a distinct GLB1‐related phenotype
por: Stockler‐Ipsiroglu, Sylvia, et al.
Publicado: (2021) -
Developments in evidence creation for treatments of inborn errors of metabolism
por: Stockler‐Ipsiroglu, Sylvia, et al.
Publicado: (2020) -
Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape
por: Bychkov, Igor, et al.
Publicado: (2022)